Skip to main navigation Skip to search Skip to main content

4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists

  • M. Wijtmans
  • , S. Celanire
  • , E. Snip
  • , M.R. Gillard
  • , E. Gelens
  • , P.P. Collart
  • , B.J. Venhuis
  • , B. Christophe
  • , ST Hulscher
  • , H. van der Goot
  • , F. Lebon
  • , H. Timmerman
  • , R.A. Bakker
  • , R. Leurs
  • , B.I. Lallemand
  • , P. Talaga
  • , I.J.P. de Esch

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Research on the therapeutic applications of the histamine H
Original languageEnglish
Pages (from-to)2944-53
JournalJournal of Medicinal Chemistry
Volume51
Issue number10
DOIs
Publication statusPublished - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of '4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists'. Together they form a unique fingerprint.

Cite this